Industry sponsors conducting preclinical or first-in-human early phase trials will find that Alberta boasts extensive capabilities for the effective evaluation of drug candidate safety and efficacy. Our network of facilities and support teams offer a full range of services, providing sponsors with high-quality data to inform future trials faster.